Entheon Biomedical Corp. (ENBI.CN)

CAD 0.17

(0.0%)

Total Debt Summary of Entheon Biomedical Corp.

  • Entheon Biomedical Corp.'s latest annual total debt in 2023 was - CAD , down 0.0% from previous year.
  • Entheon Biomedical Corp.'s latest quarterly total debt in 2024 Q3 was - CAD , down 0.0% from previous quarter.
  • Entheon Biomedical Corp. reported annual total debt of - CAD in 2022, down 0.0% from previous year.
  • Entheon Biomedical Corp. reported annual total debt of - CAD in 2021, down 0.0% from previous year.
  • Entheon Biomedical Corp. reported quarterly total debt of - CAD for 2024 Q3, down 0.0% from previous quarter.
  • Entheon Biomedical Corp. reported quarterly total debt of - CAD for 2024 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of Entheon Biomedical Corp. (2023 - 2015)

Historical Annual Total Debt of Entheon Biomedical Corp. (2023 - 2015)

Year Total Debt Total Debt Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD -100.0%
2019 3029.00 CAD 0.0%
2018 - CAD -100.0%
2017 23.15 Thousand CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%

Peer Total Debt Comparison of Entheon Biomedical Corp.

Name Total Debt Total Debt Difference
Algernon Pharmaceuticals Inc. - CAD NaN%
Asep Medical Holdings Inc 20 Thousand CAD 100.0%
BetterLife Pharma Inc. 245.23 Thousand CAD 100.0%
BioVaxys Technology Corp. - CAD NaN%
ChitogenX Inc. 3.87 Million CAD 100.0%
Rapid Dose Therapeutics Corp. 2.45 Million CAD 100.0%
Defence Therapeutics Inc. 1.74 Million CAD 100.0%
Gemina Laboratories Ltd. 285.32 Thousand CAD 100.0%
Glow Lifetech Corp. 116.18 Thousand CAD 100.0%
Lexston Life Sciences Corp. - CAD NaN%
Pharmala Biotech Holdings Inc. 253.53 Thousand CAD 100.0%
Doseology Sciences Inc. - CAD NaN%
MYND Life Sciences Inc. 3 Million CAD 100.0%
Nova Mentis Life Science Corp. - CAD NaN%
PharmaTher Holdings Ltd. - CAD NaN%
PreveCeutical Medical Inc. 3.83 Million CAD 100.0%
Telescope Innovations Corp. - CAD NaN%